Biomarkers of Oxidative Stress in HIV Seropositive Individuals on Highly Active Antiretroviral Therapy
Keywords:
Antioxidants, Highly active antiretroviral therapy, Human immune deficiency virus, Lipid peroxidation, Oxidative stressAbstract
Oxidative and nitrosative stress have been implicated in the pathogenesis and progression of human immune deficiency virus (HIV) infection, and seem to be more pronounced with commencement of highly active antiretroviral therapy (HAART). Evaluation of markers of oxidative and nitrosative stress may be useful indices for monitoring progress of infection and development of adverse drug reactions. The total antioxidant capacity (TAC), total plasma peroxides (TPP), oxidative stress index (OSI), nitric oxide (NO), reduced form of glutathione (GSH), malondialdehyde (MDA), and catalase activity were estimated in HIV-infected individuals with or without HAART. A total of 90 consenting subjects comprising of 30 HIV seropositive subjects on HAART, 30 HAART naive and 30 apparently healthy HIV seronegative controls resident in Calabar were recruited into the study. TAC, TPP, NO, GSH, MDA, and catalase activity were determined using colorimetric methods, CD4+ T cell count was done by flow cytometry while body mass index (BMI) and oxidative stress index were determined by calculation. Data was analyzed using ANOVA, LSD post hoc and Pearson’s correlation at p<0.05. The results showed that HIV seronegative controls had higher CD4+ T cell count, BMI, NO, and catalase activity and lower TPP compared to HIV seropositive individuals on HAART and HAART naive subjects (p < 0.05). Higher levels of NO and catalase and lower CD4+ T cells count, MDA, TPP, and OSI were observed in HIV on HAART compared to HAART naive (p < 0.05). OSI correlated positively with TPP (r = 0.547, p = 0.002) and negatively with TAC (r = ‒0.727, p = 0.000) in HIV HAART naive subjects only. In conclusion, HAART may be associated with reduction in lipid peroxidation and restoration of some antioxidants, and their levels may determine initiation of HAART in HIV-infected individuals.
Downloads
Published
How to Cite
Issue
Section
License
Submission of an original manuscript to the Journal will be taken to mean that it represents original work not previously published; that it is not being considered elsewhere for publication; that the author(s) agrees to assign copyright to the Journal upon acceptance for publication in the Journal, and if accepted for publication, it will be published in the digital format (PDF) and/or in print and it will not be published elsewhere in the same form, for commercial purposes, in any language, without the consent of the Publisher.